CIK 0001226616 · Non-accelerated filer<br>Smaller reporting company
MEDICINOVA INC
Sign in to watch- Ticker
- MNOV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330927979
- Phone
- 858-373-1500
- Business address
- 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,728,000
- in 1 filing
Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-06 | Okajima Masatsune VP and Head of Japanese Office | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-01-06 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-01-06 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2018-01-06 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2018-01-03 | IWAKI YUICHI President and CEO | Option exercise | +53,363 | $4.42 | $236K | 690,591 |
| 2018-01-03 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −53,363 | 0 | ||
| 2017-12-12 | Okajima Masatsune VP and Head of Japanese Office | Option exercise | +48,000 | $4.42 | $212K | 108,941 |
| 2017-12-12 | Okajima Masatsune VP and Head of Japanese Office | Option exercise · Employee Stock Option (Right to Buy) | −48,000 | 0 | ||
| 2017-11-09 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-11-09 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-11-02 | IWAKI YUICHI President and CEO | Option exercise | +21,067 | $4.42 | $93K | 637,228 |
| 2017-11-02 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −21,067 | 0 | ||
| 2017-08-21 | Ishizaka Yoshio Director | Purchase | +5,000 | $5.17 | $26K | 10,000 |
| 2017-06-08 | Kobayashi Yutaka Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-06-08 | Ishizaka Yoshio Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-15 | Kobayashi Yutaka Director | Purchase | +1,000 | $5.60 | $6K | 25,000 |
| 2017-05-12 | Kobayashi Yutaka Director | Purchase | +24,000 | $5.62 | $135K | 24,000 |
| 2017-01-18 | Okajima Masatsune VP and Head of Japanese Office | Grant or award · Employee Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2017-01-18 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2017-01-18 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +170,000 | 170,000 |
Page 7 of 8 · 149 trades